Written by FOLX clinicians, its team, and community, this content will fill a need for accessible Queer and Trans focused health content that is informative, accessible and compelling.
FOLX INSURANCE FREE
This first-of-its-kind content hub will serve as a free resource for all things Queer and Trans health. The company will leverage its new funding in order to drive national expansion and expand its offerings in sexual health and family creation later in 2021 and early 2022.Īs part of its mission to demystify health care and build a Queer and Trans centric health service for the LGBTQIA+ community, FOLX Health is also launching the FOLX Library. Upon launch, FOLX Health is available in: CA, CT, DE, FL, IL, MA, NC, NY, TX, VA, WA. All services will include unlimited on-demand clinical support with at-home lab testing (for most plans) and home-delivered medications (costs may vary based on medication).
FOLX Health will also begin releasing its sexual health and wellness offerings starting with Erectile Dysfunction (ED) treatment, soon to be followed by at-home STI Testing and Treatment, all customized for the specifics of Queer and Trans bodies. We are so mindful of the brilliant and brave Queer and Trans people who fought for this moment to happen," said Morgan Cheatham of Bessemer Venture Partners.įOLX Health is also announcing the availability of its Hormone Replacement Therapy (HRT: testosterone or estrogen) with monthly plans starting at $59 a month. It's challenging to articulate how transformative FOLX is for our community. "Our partnership with FOLX is a historical moment. This milestone comes off the heels of FOLX Health coming out of stealth in December 2020, where the company raised $4.4 million in seed funding, led by Polaris. Existing investors Define Ventures and Polaris will also participate in the round. 2, 2021 /PRNewswire/ - FOLX Health, the first digital healthcare service provider designed by and for the medical needs of the LGBTQIA+ community, today announces $25 millionin new financing led by Bessemer Venture Partners.
0 kommentar(er)
